OnabotulinumtoxinA: How deep will it go?

European Urology

Volumn 65, Issue 6, 2014, Pages 1125-1127

  Michel, Martin C ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; ACETYLCHOLINE RELEASE INHIBITOR;

CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; EFFERENT NERVE; HUMAN; NONHUMAN; OVERACTIVE BLADDER; PLACEBO EFFECT; PRIORITY JOURNAL; SENSORY NERVE; UNSPECIFIED SIDE EFFECT; URINARY FREQUENCY; FEMALE; MALE; PATHOPHYSIOLOGY; URINARY BLADDER, OVERACTIVE;

ACETYLCHOLINE RELEASE INHIBITORS; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; MALE; URINARY BLADDER, OVERACTIVE;

EID: 84899536315     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.046     Document Type: Editorial

References (10)

1. A. Mangera, A. Apostolidis, and K.E. Andersson et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders Eur Urol 65 2014 981 990
2. A. Apostolidis Treatment of overactive bladder with botulinum toxin: are there more challenges to deal with? Eur Urol 62 2012 515 517
3. H.-C. Kuo, H.-T. Liu, Y.-C. Chuang, L.A. Birder, and M.B. Chancellor Pilot study of liposome-encapsulated onabotulinumtoxinA for patients with overactive bladder: a single-center study Eur Urol 65 2014 1117 1124
4. Hanna-Mitchell AT, Wolf-Johnston AS, Barrick SR, et al. Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn. In press. http://dx.doi.org/10.1002/ nau.22508.
5. V.M. Collins, D.M. Daly, and M. Liaskos et al. OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium BJU Int 112 2013 1018 1026
6. U.S. Ha, E.Y. Park, and J.C. Kim Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity Urology 78 2011 721.e1-6
7. A. Kanai, and J.J. Wyndaele Researching bladder afferents-determining the effects of β(3)-adrenergic receptor agonists and botulinum toxin type-A Neurourol Urodyn 30 2011 684 691
8. Y.-C. Chuang, P. Tyagi, and C.C. Huang et al. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes J Urol 182 2009 786 792
9. A. Coelho, F. Cruz, C.D. Cruz, and A. Avelino Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action Eur Urol 61 2012 1178 1184
10. P. Ochodnicky, B. Uvelius, K.E. Andersson, and M.C. Michel Autonomic nervous control of the urinary bladder Acta Physiol 207 2013 16 33